BBWI
Same outlook, new face at finance
Bath & Body Works isn’t changing the plotline for 2026. The company said it’s still expecting full-year net sales to decline between 4.5% and 2.5% versus fiscal 2025, while keeping adjusted EPS guidance at $3.00 to $3.25.
That kind of “we’re not moving the goalposts” message can be soothing — or ominous, depending on how much optimism was already baked into the stock. If you’re an investor, the takeaway is simple: management isn’t seeing enough improvement to raise the bar, but it also isn’t backing away from the year’s target.
CFO bingo, but make it interim
On top of the guidance check-in, Bath & Body Works named Tom Javitch interim CFO. That’s not the kind of headline that changes the business overnight, but it does matter because the finance seat is where companies signal how confident they are about costs, cash flow, and the turnaround math.
For now, the market gets two messages at once:
- the company is holding the line on its 2026 forecast
- leadership is adjusting behind the curtain with an interim finance chief
Why investors should care
This is less about one quarter and more about the whole “can they stabilize the business?” question. If sales are still expected to shrink this year, the stock’s next big move likely depends on whether Bath & Body Works can prove the slowdown is fading — and whether the new finance setup helps, not hurts, that case.
Big picture: guidance that doesn’t budge is a statement in itself. Sometimes that means confidence. Sometimes it means the company is still waiting for the candles to light themselves.